PHARMATHUS: what changed
PHARMATHUS
Largest movements
- Receivables within one year +€60,788
up €60,788 (+60.8%), from €99,920 to €160,708
of which Trade receivables: +€61,127
- Financial fixed assets +€57,002
up €57,002 (+265%), from €21,519 to €78,521
- Tangible fixed assets -€55,082
down €55,082 (-20.2%), from €272,060 to €216,978
of which Plant, machinery and equipment: -€57,762
- Stocks and contracts +€16,071
up €16,071 (+5.1%), from €315,601 to €331,672
- Reserves +€50,000
up €50,000 (+26.1%), from €191,859 to €241,859
- Debts after one year -€32,348
down €32,348 (-19.4%), from €166,390 to €134,042
- Current portion of long-term debt +€28,588
up €28,588 (+52.2%), from €54,759 to €83,348
- Trade debts +€26,234
up €26,234 (+24.6%), from €106,710 to €132,944
- Gross operating margin +€42,147
up €42,147 (+7.4%), from €569,915 to €612,062
- Staff costs -€32,714
down €32,714 (-10.8%), from €301,934 to €269,220
- Taxes +€11,527
up €11,527 (+27.7%), from €41,587 to €53,113
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €778,884 | €845,919 | +€67,035 | +8.6% |
| Fixed assets | 21/28 | €308,579 | €305,499 | -€3,080 | -1.0% |
| Intangible fixed assets | 21 | €15,000 | €10,000 | -€5,000 | -33.3% |
| Tangible fixed assets | 22/27 | €272,060 | €216,978 | -€55,082 | -20.2% |
| Plant, machinery and equipment | 23 | €246,910 | €189,148 | -€57,762 | -23.4% |
| Furniture and vehicles | 24 | €7,152 | €5,580 | -€1,572 | -22.0% |
| Other tangible fixed assets | 26 | €17,998 | €22,251 | +€4,253 | +23.6% |
| Financial fixed assets | 28 | €21,519 | €78,521 | +€57,002 | +265% |
| Current assets | 29/58 | €470,305 | €540,420 | +€70,115 | +14.9% |
| Stocks and contracts in progress | 3 | €315,601 | €331,672 | +€16,071 | +5.1% |
| Stocks | 30/36 | €315,601 | €331,672 | +€16,071 | +5.1% |
| Amounts receivable within one year | 40/41 | €99,920 | €160,708 | +€60,788 | +60.8% |
| Trade receivables | 40 | €99,581 | €160,708 | +€61,127 | +61.4% |
| Other amounts receivable | 41 | €339 | - | -€339 | |
| Cash at bank and in hand | 54/58 | €53,496 | €48,040 | -€5,456 | -10.2% |
| Deferred charges and accrued income | 490/1 | €1,288 | - | -€1,288 | |
| Total equity and liabilities | 10/49 | €778,884 | €845,919 | +€67,035 | +8.6% |
| Equity | 10/15 | €211,218 | €261,016 | +€49,797 | +23.6% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €191,859 | €241,859 | +€50,000 | +26.1% |
| Distributable reserves | 133 | €191,859 | €241,859 | +€50,000 | +26.1% |
| Profit (loss) carried forward | 14 | €767 | €565 | -€203 | -26.4% |
| Amounts payable | 17/49 | €567,665 | €584,903 | +€17,238 | +3.0% |
| Amounts payable after more than one year | 17 | €166,390 | €134,042 | -€32,348 | -19.4% |
| Financial debts | 170/4 | €166,390 | €134,042 | -€32,348 | -19.4% |
| Amounts payable within one year | 42/48 | €400,705 | €450,861 | +€50,156 | +12.5% |
| Current portion of amounts payable after more than one year | 42 | €54,759 | €83,348 | +€28,588 | +52.2% |
| Trade debts | 44 | €106,710 | €132,944 | +€26,234 | +24.6% |
| Suppliers | 440/4 | €106,710 | €132,944 | +€26,234 | +24.6% |
| Taxes, remuneration and social security | 45 | €73,771 | €74,045 | +€274 | +0.4% |
| Taxes | 450/3 | €21,609 | €34,819 | +€13,210 | +61.1% |
| Remuneration and social security | 454/9 | €52,162 | €39,225 | -€12,937 | -24.8% |
| Other amounts payable | 47/48 | €165,465 | €160,525 | -€4,940 | -3.0% |
| Accrued charges and deferred income | 492/3 | €571 | - | -€571 | |
| Remuneration, social security and pensions | 62 | €301,934 | €269,220 | -€32,714 | -10.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €67,746 | €68,255 | +€509 | +0.8% |
| Other operating charges | 640/8 | €282 | €490 | +€208 | +73.8% |
| Gross operating margin | 9900 | €569,915 | €612,062 | +€42,147 | +7.4% |
| Operating profit (loss) | 9901 | €199,953 | €274,097 | +€74,144 | +37.1% |
| Financial income | 75/76B | €30 | - | -€30 | |
| Recurring financial income | 75 | €30 | - | -€30 | |
| Financial charges | 65/66B | €5,730 | €11,186 | +€5,456 | +95.2% |
| Recurring financial charges | 65 | €5,730 | €11,186 | +€5,456 | +95.2% |
| Profit (loss) for the period before taxes | 9903 | €194,253 | €262,911 | +€68,658 | +35.3% |
| Income taxes | 67/77 | €41,587 | €53,113 | +€11,527 | +27.7% |
| Profit (loss) for the period | 9904 | €152,666 | €209,797 | +€57,131 | +37.4% |
| Profit (loss) for the period to be appropriated | 9905 | €152,666 | €209,797 | +€57,131 | +37.4% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.